Skip to main content
. 2023 Jul 7;34(7):1234–1243. doi: 10.1021/acs.bioconjchem.3c00116

Figure 3.

Figure 3

Comparison of binding ability of linear peptide 3 and its cyclic variant peptide 6. (A) Living AB5075-VUB cells (seen in phase contrast images) bound by both peptides (labeled by sulfoCy3). (B) Comparison of maximum fluorescence intensity signal measured on AB5075-VUB cells for (n = 300/biological replicate) the cyclic and linear peptide. Scale bar 5 μm. All data were collected in biological triplicate.